These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 11966697)
1. Cutaneous adverse reactions to clindamycin: results of skin tests and oral exposure. Lammintausta K; Tokola R; Kalimo K Br J Dermatol; 2002 Apr; 146(4):643-8. PubMed ID: 11966697 [TBL] [Abstract][Full Text] [Related]
2. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon? Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303 [TBL] [Abstract][Full Text] [Related]
3. Value of patch tests in clindamycin-related drug eruptions. Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110 [TBL] [Abstract][Full Text] [Related]
4. Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature. Papakonstantinou E; Müller S; Röhrbein JH; Wieczorek D; Kapp A; Jakob T; Wedi B Contact Dermatitis; 2018 Apr; 78(4):274-280. PubMed ID: 29356000 [TBL] [Abstract][Full Text] [Related]
5. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing. El Khoury M; Assier H; Gener G; Paul M; Haddad C; Chosidow O; Wolkenstein P; Ingen-Housz-Oro S Br J Dermatol; 2018 Oct; 179(4):978-979. PubMed ID: 29747236 [No Abstract] [Full Text] [Related]
14. The use of skin testing in the investigation of cutaneous adverse drug reactions. Barbaud A; Reichert-Penetrat S; Tréchot P; Jacquin-Petit MA; Ehlinger A; Noirez V; Faure GC; Schmutz JL; Béné MC Br J Dermatol; 1998 Jul; 139(1):49-58. PubMed ID: 9764148 [TBL] [Abstract][Full Text] [Related]
15. Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics. Pinho A; Marta A; Coutinho I; Gonçalo M Contact Dermatitis; 2017 Apr; 76(4):204-209. PubMed ID: 27910104 [TBL] [Abstract][Full Text] [Related]
16. Allergy to beta-lactam antibiotics in children. Ponvert C; Le Clainche L; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J Pediatrics; 1999 Oct; 104(4):e45. PubMed ID: 10506270 [TBL] [Abstract][Full Text] [Related]
17. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. Hassoun-Kheir N; Bergman R; Weltfriend S Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159 [TBL] [Abstract][Full Text] [Related]
18. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis. Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561 [TBL] [Abstract][Full Text] [Related]
19. Direct oral provocation tests in non-immediate mild cutaneous reactions related to beta-lactam antibiotics. Vezir E; Dibek Misirlioglu E; Civelek E; Capanoglu M; Guvenir H; Ginis T; Toyran M; Kocabas CN Pediatr Allergy Immunol; 2016 Feb; 27(1):50-4. PubMed ID: 26619970 [TBL] [Abstract][Full Text] [Related]
20. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Lammintausta K; Kortekangas-Savolainen O Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]